Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2025-12-31 @ 5:14 PM
Study NCT ID:
NCT05722405
Status:
UNKNOWN
Last Update Posted:
2023-02-10
First Post:
2023-02-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ixazomib Plus Low-dose Lenalidomide Versus Ixazomib Alone for Maintenance Treatment of High Risk Multiple Myeloma
Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Organization: